We can't find the internet
Attempting to reconnect
17616.1 PFLS-LS
17616.1 PFLS-LS
Zusammenfassung
New therapeutic approach to Alzheimer's disease: assessing active immunization and anti-aggregation small molecules in a novel mouse model of Tau pathology
Weitere Texte
Abstract
Alzheimer's disease (AD) is a devastating neurodegenerative disease with increasing incidence due to an aging world population and an absence of disease-modifying therapies. Our objective is to develop a novel genetic mouse model to demonstrate efficacy of therapeutics (small molecules and vaccines) to prevent the progression of the Tau pathology in order to evaluate their therapeutic value for testing in AD patients.
Beteiligte
Andreas Muhs
Wirtschaftspartner
AC Immune SA Andreas Muhs Bâtiment B / EPFL Innovation Park 1015 Lausanne VD CH
Bernard Schneider
Kontaktperson
bernard.schneider@epfl.ch
EPFL IC IIF LABOS Bernard Schneider Station 9, Bâtiment AI 2241 1015 Lausanne VD CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2015-08-31
- Enddatum
- 2018-08-31
- Bewilligte Gesamtkosten
- CHF 385553.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%